8-K 1 d8k.txt FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (date of earliest event reported): October 23, 2003 UROLOGIX, INC. -------------- (Exact name of Registrant as specified in its charter) Minnesota 0-28414 41-1697237 --------- ------- ---------- (State or other jurisdiction (Commission File (I.R.S. Employer of incorporation) Number) Identification No.) 14405 21st Avenue North Minneapolis, MN 55447 ------------------ ----- (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (763) 475-1400 Items 1-6 and 8-11 are not applicable and therefore omitted. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS. (c) Exhibits The following is furnished as an exhibit to this Current Report: Exhibit No. Description of Exhibit ----------- ---------------------- 99.1 Press release issued October 23, 2003. ITEM 12. DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION. On October 23, 2003, Urologix, Inc. issued a press release, furnished as Exhibit 99.1 to this Form 8-K, disclosing material non-public information regarding its results of operations for the quarter ended September 30, 2003. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. UROLOGIX, INC. By /s/ Fred B. Parks ---------------------- Fred B. Parks Chief Executive Officer Dated: October 23, 2003